Stem Cell Therapy for Macular Degeneration in Tijuana

Medically Reviewed by Dr. José Jiménez
Founder & Medical Director, Renovo Health & Beauty
Board-Elected Member, American Academy of Regenerative Medicine | 32+ Years of Medical Experience
Last Reviewed: July 2026

Macular degeneration (AMD) is a leading cause of vision loss, particularly in adults over 50. At Renovo Health and Beauty in Tijuana, patients can consult with Dr. Jiménez about regenerative stem cell approaches being studied as a complement to standard ophthalmologic care. Because vision-related treatment carries especially high stakes, Renovo’s approach emphasizes thorough intake and honest expectation-setting over broad promises, so patients can make an informed decision in partnership with their existing eye care team.

Many patients come to us after receiving a dry or wet AMD diagnosis and wanting to understand every option available to them, not just the ones covered by their existing ophthalmologist’s practice. This page explains how a Tijuana consultation works, what current regenerative approaches involve, and how Renovo coordinates with your existing eye care rather than replacing it.

Get an Appointment

Complete The Form Below And We’ll Get Back To You Immediately.

What Is Macular Degeneration?

AMD affects the macula, the part of the retina responsible for sharp, central vision. It progresses gradually and is typically categorized as dry or wet, with different management approaches for each. Any regenerative treatment should be discussed alongside your ophthalmologist’s existing management plan, since AMD staging and progression are best tracked by the specialist already familiar with your retinal history.

Get an Appointment

Complete The Form Below And We’ll Get Back To You Immediately.

The Renovo Approach

Treatment begins with a thorough consultation reviewing your diagnosis, prior eye care, and current vision status. Dr. Jiménez will determine candidacy before recommending a stem cell protocol, always in coordination with your existing ophthalmology records where available.

Because eye-related regenerative treatment is still an evolving area of medicine, our team spends extra time during intake reviewing your imaging history and prior treatments so any recommendation reflects a complete understanding of your case, not just the symptoms you describe on a phone call.

Setting Realistic Expectations

Vision-related regenerative therapy is an evolving field. Renovo is committed to transparent conversations about what stem cell therapy can and cannot be expected to achieve for AMD, so patients can make a fully informed decision before travel.

Coordinating With Your Eye Care Team

Renovo encourages patients to keep their regular ophthalmologist informed throughout the process. Sharing updates on your vision status after treatment helps your home eye care provider track any changes over time and ensures your overall AMD management stays coordinated rather than fragmented across providers.

What to Bring to Your Consultation

If you have recent optical coherence tomography (OCT) scans, visual acuity test results, or notes from your ophthalmologist, bringing these to your consultation helps Dr. Jiménez evaluate your candidacy more thoroughly and gives you a more informed conversation about what to expect.

stem cell therapy macular degeneration Tijuana

Dry vs. Wet AMD: Why It Matters for Candidacy

Dry AMD, the more common form, progresses gradually as the macula thins over time, while wet AMD involves abnormal blood vessel growth that can cause more rapid vision changes and typically requires more urgent, ongoing management. Because these two forms behave so differently, your specific diagnosis plays a major role in how Dr. Jiménez approaches your consultation and what, if anything, he recommends discussing further with your ophthalmologist before considering any additional treatment.

The Consultation Process, Step by Step

Your first conversation with our care team focuses on understanding your diagnosis timeline, current vision status, and any treatments you’ve already tried. From there, Dr. Jiménez reviews any imaging you’ve provided and discusses whether a stem cell consultation makes sense for your situation. If it does, he’ll explain what the visit itself involves, how candidacy is finally confirmed in person, and what kind of follow-up monitoring would be appropriate afterward.

Why Transparency Matters Most for Eye-Related Care

Vision loss is understandably one of the most emotionally difficult diagnoses patients face, which unfortunately makes this space attractive to providers willing to overpromise. Renovo takes the opposite approach: our team would rather have an honest conversation about the current limits of regenerative treatment for AMD than make a claim we can’t stand behind. If, after your consultation, we don’t believe you’re a strong candidate, we’ll tell you directly rather than proceeding anyway.

Who Typically Reaches Out

Patients who contact Renovo about AMD are often at different points in their journey — some were recently diagnosed and are researching every possible option, while others have been managing the condition for years and are looking for anything that might complement their existing care. Both groups are welcome to schedule a consultation, and Dr. Jiménez tailors the conversation to where you are in that process rather than assuming a single starting point for everyone.

A Collaborative, Not Competing, Approach

We view a stem cell consultation as an addition to your care team, not a replacement for it. Where appropriate, we’re glad to correspond directly with your ophthalmologist’s office to share relevant updates, provided you authorize that communication, so your full care team stays aligned on your treatment history and current status.

Scheduling Your Consultation

Starting the process is straightforward: reach out through WhatsApp or our consultation form, share a summary of your AMD diagnosis and any recent eye care history, and our team will schedule a time to talk through your specific situation with Dr. Jiménez. There’s no cost or obligation attached to this first conversation.

How AMD Progression Is Typically Monitored

Ophthalmologists typically track AMD progression through regular OCT imaging, visual acuity testing, and sometimes an Amsler grid test patients can use at home to notice changes in central vision between appointments. If you decide to move forward with a consultation at Renovo, continuing this monitoring schedule with your regular eye care provider remains important, since it gives everyone involved in your care the clearest picture of how your condition is or isn’t changing over time.

We also encourage patients to keep a simple log of any changes they notice in daily activities — reading, recognizing faces, or driving at night, for example — since these practical details often complement the clinical data your ophthalmologist collects and can be useful context during your consultation with Dr. Jiménez.

Frequently Discussed Risk Factors

Patients often ask whether certain factors made their AMD more likely, and while this isn’t the focus of a stem cell consultation specifically, it’s a common part of the broader conversation. Age, family history, smoking history, and cardiovascular health are all commonly discussed risk factors for AMD. Understanding your own risk profile can help frame the conversation about realistic goals for any additional treatment you’re considering, including a stem cell consultation at Renovo.

Frequently Asked Questions (FAQPage schema-ready)

Outcomes vary by patient and disease stage. Dr. Jiménez will discuss realistic expectations for your specific case during consultation — no outcome can be guaranteed.

Yes, bringing recent imaging and records from your eye care provider helps Renovo evaluate candidacy more accurately.

No — it’s intended to complement, not replace, your ongoing ophthalmologic care.

Yes. Your specific diagnosis affects candidacy and how your consultation is approached, which is why current imaging and records are so important to bring.

With your authorization, yes — we’re glad to share relevant updates with your existing eye care provider so your overall management stays coordinated.

Most consultations are scheduled within a few business days of your initial message, and the conversation itself typically takes about 30 to 45 minutes.

Recent OCT scans, visual acuity test results, and notes from your ophthalmologist are the most useful documents for evaluating candidacy during your consultation.